Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Julie R. Gralow
Based on 89 articles published since 2007
||||
Expertise Level
The expertise of Julie R. Gralow ranks in the
  • Top 0.022%
  • ... of 251,815 published authors worldwide on Breast Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 89 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Gralow, Julie   ·   Gralow, J   ·   Gralow, Julie R   ·   Gralow, J R
Work Locations
Details
Most likely:    University of Washington   Contact    
2017
  • Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Global Health, University of Washington, Seattle, WA, USA. · Department of Epidemiology, University of Washington, Seattle, WA, USA; PATH, Seattle, WA, USA. · PATH, Seattle, WA, USA. · Department of Global Health, University of Washington, Seattle, WA, USA; PATH, Seattle, WA, USA. · Department of Global Health, University of Washington, Seattle, WA, USA; Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Radiology, University of Washington, Seattle, WA, USA. · Department of Global Health, University of Washington, Seattle, WA, USA; Department of Radiation Oncology, University of Washington, Seattle, WA, USA. · Department of Global Health, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA. · Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Surgery, University of Washington, Seattle, WA, USA. Electronic address: · Pubmed 28971827
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
2016
  • Division of Hematology-Oncology, Department of Internal Medicine, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX, USA. · SWOG Statistical Center, Seattle, WA, USA. · University of Michigan, Ann Arbor, MI, USA. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Women and Infants Hospital of Rhode Island and Warren Alpert Medical School of Brown University, Providence, RI, USA. · Genentech, Inc., San Francisco, CA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Hematology Oncology Consultants, Inc., Westerville, OH, USA. · Columbus NCI Community Oncology Research Program, Columbus, OH, USA. · Loma Linda University Cancer Center, Loma Linda, CA, USA. · Gibbs Cancer Center and Research Institute/Southeast Clinical Oncology Research (SCOR) Consortium NCORP/Upstate Carolina CCOP (previous), Spartanburg, SC, USA. · Yale University, New Haven, CT, USA. · Arizona Cancer Center, Tucson, AZ, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27393622
  • University of California, Davis, California. · University of Pittsburgh, Pittsburgh, Pennsylvania. · University of Washington/Fred Hutchinson Cancer Research Center, Seattle, Washington. · AbbVie Laboratories, North Chicago, Illinois. · Pubmed 26801247
  • School of Nursing, College of Medicine, National Taiwan University, No. 1, Jen-Ai Rd., Sec. 1, Taipei, 10051, Taiwan; Department of Nursing, National Taiwan University Hospital, No. 7, Zhong-Shan S. Rd., Taipei, 10002, Taiwan. · Rice University, 6100 Main St, MS-760, Houston, TX 77005-1827, United States. · Department of Rehabilitation Medicine, University of Washington, Box 356490, 325 Ninth Avenue, Seattle, WA, 98104, United States. Electronic address: · Biobehavioral Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D5-220, Seattle, WA, 98109, United States; Department of Psychiatry and Behavioral Sciences, University of Washington, 1959 NE Pacific Street, Box 356560, Seattle, WA, 98195, United States. · Department of Psychiatry and Behavioral Sciences, University of Washington, 1959 NE Pacific Street, Box 356560, Seattle, WA, 98195, United States. · Division of Medical Oncology, University of Washington School of Medicine, 825 Eastlake Ave E., Seattle, WA, 98109-1023, United States; Breast Medical Oncology, Seattle Cancer Care Alliance, 825 Eastlake Ave East, G3-630, Seattle, WA, 98109, United States. · Pubmed 27065357
  • College of Pharmacy, University of Michigan, Ann Arbor, MI, USA. · SWOG Statistical Center, Seattle, WA, USA. · University of Michigan, School of Public Health, Ann Arbor, MI, USA. · Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA. · London Health Sciences Center/National Cancer Institute of Canada Clinical, Trials Group, London, ON, Canada. · Wichita NCORP, Wichita, KS, USA. · Kaiser Permanente NCORP, Portland, OR, USA. · Arizona Cancer Center, University of Arizona, Tucson, AZ, USA. · Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA. · Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA. · University of California Irvine Medical Center, Chao Family Comprehensive, Cancer Center, Orange, CA, USA. · Pubmed 26859101
  • Department of Radiology, Massachusetts General Hospital, Boston, MA (CDL); Department of Radiology, University of Washington Medical Center, Seattle, WA (JML, DSH, GK, SCP); Seattle Cancer Care Alliance, Seattle, WA (JML, SCP); Department of Radiology, University of Wisconsin-Madison, Madison, WI (WBD); Department of Pathology, University of Washington Medical Center, Seattle, WA (MHR); Fred Hutchinson Cancer Research Center, Seattle, WA, (PP, JG); Department of Medical Oncology, University of Washington Medical Center, Seattle, WA (JG). · Department of Radiology, Massachusetts General Hospital, Boston, MA (CDL); Department of Radiology, University of Washington Medical Center, Seattle, WA (JML, DSH, GK, SCP); Seattle Cancer Care Alliance, Seattle, WA (JML, SCP); Department of Radiology, University of Wisconsin-Madison, Madison, WI (WBD); Department of Pathology, University of Washington Medical Center, Seattle, WA (MHR); Fred Hutchinson Cancer Research Center, Seattle, WA, (PP, JG); Department of Medical Oncology, University of Washington Medical Center, Seattle, WA (JG). · Pubmed 26744477
  • Department of Oncology, Mayo Clinic, Rochester, MN, USA. · University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA. · Department of Medicine and Center for the Study of Aging and Human Development, Duke University, Durham, NC, USA. · Novant Health Oncology Specialists, Winston Salem, NC, USA. · Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY, USA. · Cancer Center Clinical Research Offices, Mayo Clinic, Rochester, MN, USA. · Department of Oncology, Johns Hopkins University, Baltimore, MD, USA. · Division of Medical Oncology, University of Washington, Seattle, WA, USA. · City of Hope, Duarte, CA, USA. · Pubmed 25994447
2015
  • Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Northwest Health Communications, Edmonds, WA, USA. · University of Wisconsin Comprehensive Cancer Center, Madison, WI, USA. · University of California, Los Angeles, CA, USA. · Acibadem Maslak Hospital Breast Health, Istanbul, Turkey. · Programme of Action for Cancer Therapy, International Atomic Energy Agency, Lisbon, Portugal. · Champalimaud Cancer Center, Lisbon, Portugal. · Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Uganda Cancer Institute, Kampala, Uganda. · Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · University Malaya Medical Centre, Kuala Lumpur, Malaysia. · Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. Electronic address: · Pubmed 25752564
  • Department of Medical Oncology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China. · Division of Nephrology, Harborview Medical Center, University of Washington, Seattle, WA, 98195, USA. · Division of Oncology, Department of Medicine, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, 98109, USA. · Department of Medicine, University of Washington, Seattle, WA, 98195, USA. · Department of Pathology, University of Washington, Seattle, WA, 98195, USA. · Division of Oncology, Department of Medicine, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, 98109, USA. · Pubmed 26197890
  • Scott D. Ramsey, Julie R. Gralow, Dana K. Mirick, William Barlow, Ruth Etzioni, and David Mummy, Fred Hutchinson Cancer Research Center; Scott D. Ramsey, Julie R. Gralow, Rahber Thariani, and David L. Veenstra, University of Washington, Seattle, WA; and N. Lynn Henry, University of Michigan, Ann Arbor, MI. · Scott D. Ramsey, Julie R. Gralow, Dana K. Mirick, William Barlow, Ruth Etzioni, and David Mummy, Fred Hutchinson Cancer Research Center; Scott D. Ramsey, Julie R. Gralow, Rahber Thariani, and David L. Veenstra, University of Washington, Seattle, WA; and N. Lynn Henry, University of Michigan, Ann Arbor, MI. · Pubmed 25332254
2014
  • Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA. · Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA. · Department of General Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA. · Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA. · Indiana Institute for Personalized Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Mayo Clinic, Scottsdale, AZ 85054, USA. · Mayo Clinic, Jacksonville, FL 32224, USA. · BCCA - Vancouver Cancer Center, Vancouver, BC, V5Z 4E6, USA. · Department of Internal Medicine , Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612, USA. · Research Advocacy Network, Plano, TX 75093, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA. · University of Washington, Seattle, WA 98195, USA. · Department of Oncology, Montefiore Hospital and Medical Center, Bronx, NY 10467, USA. · Cancer Institute and University of Pittsburgh Cancer Center, Pittsburgh, PA 15232, USA. · Department of Medicine, Stanford University, Stanford, CA 94305, USA. · Pubmed 25117820
  • University of Washington School of Medicine/Seattle Cancer Care Alliance, 825 Eastlake Avenue East, G3-630, Seattle, WA, 98109, USA, · Pubmed 24352574
  • Department of Pathology, Yale University School of Medicine, 310 Cedar Street BML116, New Haven, CT 06520, USA. · Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. · Department of Medical Oncology, Pitie-Salpetriere Hospital, 83 Boulevard de l'Hôpital, 75013 Paris, France. · Section of Biostatistics, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. · Department of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, 825 Eastlake Avenue East, Seattle, WA 98109, USA. · Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 8, New York, NY 10065, USA. · Division of Hematology/Oncology, University of Pittsburgh Cancer Institute and UPMC Cancer Center, 5150 Centre Avenue, Pittsburgh, PA 15232, USA. · 1] Department of Medical Oncology, Papageorgiou General Hospital, Aristotle University of Thessaloniki School of Medicine, Efkarpia Peripheral Road Stavroupoli, 56429 Thessaloniki, Greece [2] Hellenic Cooperative Oncology Group (HeCOG), Laskaridou 1, 11524 Athens, Greece. · Anatomic Pathology, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA. · 1] Hellenic Cooperative Oncology Group (HeCOG), Laskaridou 1, 11524 Athens, Greece [2] Second Department of Internal Medicine Propaedeutic, Oncology Section, Attikon University Hospital, University of Athens Medical School, 1 Rimini Street, Haidari, 12462 Athens, Greece. · Department of Hematology/Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA. · Pubmed 25117817
2012
  • University of Washington School of Medicine, Seattle, Washington, USA. · Pubmed 23176010
2009
  • Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington, USA. · Pubmed 19555589
2016
  • From the Massachusetts General Hospital Cancer Center, Avon International Breast Cancer Research Program (P.E.G.), Harvard Medical School (P.E.G., E.W.), and Dana-Farber Cancer Institute (E.W.), Boston; the Department of Oncology, Mayo Clinic, Rochester, MN (J.N.I., J.S.K.); Sunnybrook Odette Cancer Centre, Toronto (K.I.P.), British Columbia Cancer Agency, Vancouver (K.G.), Canadian Cancer Trials Group, Queen's University, Kingston, ON (K.W., D.T., W.R.P.), Department of Oncology, McMaster University, Hamilton, ON (T.W.), and Dalhousie University Faculty of Medicine, Moncton Hospital, Moncton, NB (S.R.) - all in Canada; Virginia Cancer Specialists-US Oncology Network, Fairfax (N.J.R.); University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill (H.M.); University of Washington School of Medicine, Seattle (J.G.); Center of Oncology and Hematology, Wilheminen Hospital, Vienna (K.S.-W.); Colorado Cancer Research Program, Denver (K.S.); Johns Hopkins Kimmel Cancer Center, Baltimore (A.C.W.); Memorial Sloan Kettering Cancer Center, New York (C.H.); University of Arizona, Tucson (A.S.); and Highlands Oncology Group, Fayetteville, AR (J.T.B.). · Pubmed 27264120
2015
  • From the Cleveland Clinic Foundation, Cleveland (H.C.F.M.); SWOG Cancer Research Group Statistical Center, Fred Hutchinson Cancer Research Center (J.M.U., W.E.B.), and Seattle Cancer Care Alliance and University of Washington (J.G.) - all in Seattle; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (K.-A.P., P.A.F.), Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) (K.-A.P., P.A.F., J.F.F.), Calvary Mater Hospital, Newcastle, NSW (F.B., J.M.L., J.F.F.), and University of Sydney, Sydney (F.B.) - all in Australia; International Breast Cancer Study Group (IBCSG), Bern, Switzerland (K.-A.P., P.A.F.); National Institute of Oncology, Budapest, Hungary (E.H.); Auckland Regional Cancer and Blood Service, Auckland, New Zealand (D.P.); Fox Chase Cancer Center, Philadelphia (L.J.G.); Instituto de Enfermedades Neoplasicas (H.L.G.) and Oncosalud SAC (C.S.V.), Lima, Peru; Dana-Farber Cancer Institute (A.H.P., R.D.G.) and IBCSG Statistical Center (R.D.G.) - both in Boston; Wichita Community Clinical Oncology Program, Wichita (S.R.D.), and University of Kansas, Westwood (C.J.F.) - both in Kansas; University of Southern California Norris Cancer Center, Los Angeles (A.A.G.), the Angeles Clinic and Research Institute, Santa Monica (S.M.), and University of California at Irvine Chao Family Comprehensive Cancer Center, Orange (F.L.M) - all in California; National Cancer Institute, Division of Cancer Prevention, Bethesda, MD (L.M.); M.D. Anderson Cancer Center, Houston (G.N.H.); and Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL (K.S.A.). · Pubmed 25738668
  • Dawn L. Hershman, Katherine D. Crew, Danielle Awad, and Heather Greenlee, Columbia University Medical Center, New York, NY; Joseph M. Unger, Danika L. Lew, and Cathee Till, Southwest Oncology Group Statistical Center; Joseph M. Unger, Julie Gralow, Danika L. Lew, Cathee Till, and Carol M. Moinpour, Fred Hutchinson Cancer Research Center, Seattle, WA; Shaker R. Dakhil, Cancer Center of Kansas, Wichita, KS; Lori M. Minasian, National Cancer Institute, Bethesda, MD; James L. Wade III, Central Illinois Community Clinical Oncology Program/Cancer Care Specialists of Central Illinois, Decatur, IL; and Frank L. Meyskens, University of California at Irvine, Chao Family Comprehensive Cancer Center, Orange, CA. · Dawn L. Hershman, Katherine D. Crew, Danielle Awad, and Heather Greenlee, Columbia University Medical Center, New York, NY; Joseph M. Unger, Danika L. Lew, and Cathee Till, Southwest Oncology Group Statistical Center; Joseph M. Unger, Julie Gralow, Danika L. Lew, Cathee Till, and Carol M. Moinpour, Fred Hutchinson Cancer Research Center, Seattle, WA; Shaker R. Dakhil, Cancer Center of Kansas, Wichita, KS; Lori M. Minasian, National Cancer Institute, Bethesda, MD; James L. Wade III, Central Illinois Community Clinical Oncology Program/Cancer Care Specialists of Central Illinois, Decatur, IL; and Frank L. Meyskens, University of California at Irvine, Chao Family Comprehensive Cancer Center, Orange, CA. · Pubmed 25940724
  • Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Pubmed 24923811
2014
  • Ann H. Partridge, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center; Beverly Moy, Massachusetts General Hospital, Boston, MA; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria; Michael A. Danso, Virginia Oncology Associates, Norfolk, VA; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Nancy E. Davidson, University of Pittsburgh Cancer Institute/University of Pittsburgh Medical Center, Pittsburgh, PA; Angelo Di Leo, Sandro Pitigliani Medical Oncology Unit, Prato, Italy; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Douglas Yee, University of Minnesota/Masonic Cancer Center, Minneapolis, MN; Shelley B. Brundage, Patient Representative, Washington, DC; Maggie Wilcox, Independent Cancer Patients' Voice; and Ian E. Smith, Royal Marsden Hospital, London, United Kingdom. · Pubmed 25185096
  • Edith A. Perez, Gerardo Colon-Otero, the Mayo Clinic, Jacksonville; Eleftherios Mamounas, University of Florida Health Cancer Center-Orlando Health, Orlando, FL; Edward H. Romond, University of Kentucky, Lexington, KY; Vera J. Suman, Mayo Clinic, Rochester, MN; Jong-Hyeon Jeong, Priya Rastogi, University of Pittsburgh; Nancy E. Davidson, University of Pittsburgh Cancer Institute; Norman Wolmark, Allegheny General Hospital, Pittsburgh, PA; George Sledge, Stanford University School of Medicine, Stanford; Silvana Martino, The Angeles Clinic and Research Institute, Santa Monica, CA; Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jo Anne Zujewski, National Institutes of Health, Rockville, MD. · Edith A. Perez, Gerardo Colon-Otero, the Mayo Clinic, Jacksonville; Eleftherios Mamounas, University of Florida Health Cancer Center-Orlando Health, Orlando, FL; Edward H. Romond, University of Kentucky, Lexington, KY; Vera J. Suman, Mayo Clinic, Rochester, MN; Jong-Hyeon Jeong, Priya Rastogi, University of Pittsburgh; Nancy E. Davidson, University of Pittsburgh Cancer Institute; Norman Wolmark, Allegheny General Hospital, Pittsburgh, PA; George Sledge, Stanford University School of Medicine, Stanford; Silvana Martino, The Angeles Clinic and Research Institute, Santa Monica, CA; Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jo Anne Zujewski, National Institutes of Health, Rockville, MD. · Pubmed 25332249
  • Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA. · Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA. · Pubmed 24934783
  • Department of Pharmacy, University of Washington, 1959 NE Pacific St, Box 357630, Seattle, WA, 98195, USA. · Pubmed 24407530
2013
  • Department of Pharmacy, University of Washington, Seattle, WA 98195, USA. · Pubmed 24236631
  • Departments of Pharmacy, Biostatistics, Epidemiology, and Health Services, University of Washington, Seattle, WA 98101, USA. · Pubmed 23833124
  • University of Washington, Seattle, WA 98195, USA. · Pubmed 23642440
2012
  • University of Washington School of Medicine, Seattle, WA 98104, USA. · Pubmed 22443523
  • Department of Surgery, Division of Surgical Oncology, University of Washington Medical Center, 1959 NE Pacific St., Seattle, WA 98195-6410, USA. · Pubmed 22723506
2011
  • Seattle Cancer Care Alliance, 825 Eastlake Ave East, Seattle, WA 98109-1023, USA. · Pubmed 21220618
  • Department of Medicine, University of Washington, Seattle, Washington, USA. · Pubmed 21750198
  • Division of Nuclear Medicine and Medical Oncology, University of Washington, Seattle, Washington 98109, USA. · Pubmed 21364034
2010
  • University of Washington, WA, USA. · Pubmed 21778572
  • Division of Nuclear Medicine, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington 98195-7987, USA. · Pubmed 20237040
  • Division of Oncology, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington 98119, USA. · Pubmed 20568589
  • Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington 98104, USA. · Pubmed 20545872
  • Medical Oncology and Nuclear Medicine, Department of Medicine, University of Washington, Seattle, Washington 98109, USA. · Pubmed 20460489
  • Division of Medical Oncology, University of Washington, 825 Eastlake Ave, E. MS G3-630, Seattle, WA 98109, USA. · Pubmed 20308661
2009
  • Medical Oncology, Fred Hutchinson Cancer Research Center/University of Washington, Seattle Cancer Care Alliance, Seattle, Washington 98109-1023, USA. · Pubmed 19925032
  • Department of Medicine, Medical Oncology, University of Washington School of Medicine, Seattle, WA, USA. · Pubmed 19732686
Probable:    Harvard University   Contact    
2016
  • Department of Radiology, Massachusetts General Hospital, Boston, MA (CDL); Department of Radiology, University of Washington Medical Center, Seattle, WA (JML, DSH, GK, SCP); Seattle Cancer Care Alliance, Seattle, WA (JML, SCP); Department of Radiology, University of Wisconsin-Madison, Madison, WI (WBD); Department of Pathology, University of Washington Medical Center, Seattle, WA (MHR); Fred Hutchinson Cancer Research Center, Seattle, WA, (PP, JG); Department of Medical Oncology, University of Washington Medical Center, Seattle, WA (JG). · Department of Radiology, Massachusetts General Hospital, Boston, MA (CDL); Department of Radiology, University of Washington Medical Center, Seattle, WA (JML, DSH, GK, SCP); Seattle Cancer Care Alliance, Seattle, WA (JML, SCP); Department of Radiology, University of Wisconsin-Madison, Madison, WI (WBD); Department of Pathology, University of Washington Medical Center, Seattle, WA (MHR); Fred Hutchinson Cancer Research Center, Seattle, WA, (PP, JG); Department of Medical Oncology, University of Washington Medical Center, Seattle, WA (JG). · Pubmed 26744477
2016
  • From the Massachusetts General Hospital Cancer Center, Avon International Breast Cancer Research Program (P.E.G.), Harvard Medical School (P.E.G., E.W.), and Dana-Farber Cancer Institute (E.W.), Boston; the Department of Oncology, Mayo Clinic, Rochester, MN (J.N.I., J.S.K.); Sunnybrook Odette Cancer Centre, Toronto (K.I.P.), British Columbia Cancer Agency, Vancouver (K.G.), Canadian Cancer Trials Group, Queen's University, Kingston, ON (K.W., D.T., W.R.P.), Department of Oncology, McMaster University, Hamilton, ON (T.W.), and Dalhousie University Faculty of Medicine, Moncton Hospital, Moncton, NB (S.R.) - all in Canada; Virginia Cancer Specialists-US Oncology Network, Fairfax (N.J.R.); University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill (H.M.); University of Washington School of Medicine, Seattle (J.G.); Center of Oncology and Hematology, Wilheminen Hospital, Vienna (K.S.-W.); Colorado Cancer Research Program, Denver (K.S.); Johns Hopkins Kimmel Cancer Center, Baltimore (A.C.W.); Memorial Sloan Kettering Cancer Center, New York (C.H.); University of Arizona, Tucson (A.S.); and Highlands Oncology Group, Fayetteville, AR (J.T.B.). · Pubmed 27264120
  • Stuart M. Lichtman and Maria Theodoulou, Memorial Sloan Kettering Cancer Center, New York, NY; Constance T. Cirrincione, Duke University; Harvey Jay Cohen, Duke University Medical Center, Durham; Gustave Magrinat, Cone Health Cancer Center, Greensboro; Hyman B. Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte, CA; Aminah Jatoi, Mayo Clinic, Rochester, MN; Antonio C. Wolff, The Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD; Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA; and Daniel E. Morganstern, Dana-Farber Cancer Institute, Boston, MA. · Stuart M. Lichtman and Maria Theodoulou, Memorial Sloan Kettering Cancer Center, New York, NY; Constance T. Cirrincione, Duke University; Harvey Jay Cohen, Duke University Medical Center, Durham; Gustave Magrinat, Cone Health Cancer Center, Greensboro; Hyman B. Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte, CA; Aminah Jatoi, Mayo Clinic, Rochester, MN; Antonio C. Wolff, The Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD; Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA; and Daniel E. Morganstern, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 26755510
2015
  • From the Cleveland Clinic Foundation, Cleveland (H.C.F.M.); SWOG Cancer Research Group Statistical Center, Fred Hutchinson Cancer Research Center (J.M.U., W.E.B.), and Seattle Cancer Care Alliance and University of Washington (J.G.) - all in Seattle; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (K.-A.P., P.A.F.), Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) (K.-A.P., P.A.F., J.F.F.), Calvary Mater Hospital, Newcastle, NSW (F.B., J.M.L., J.F.F.), and University of Sydney, Sydney (F.B.) - all in Australia; International Breast Cancer Study Group (IBCSG), Bern, Switzerland (K.-A.P., P.A.F.); National Institute of Oncology, Budapest, Hungary (E.H.); Auckland Regional Cancer and Blood Service, Auckland, New Zealand (D.P.); Fox Chase Cancer Center, Philadelphia (L.J.G.); Instituto de Enfermedades Neoplasicas (H.L.G.) and Oncosalud SAC (C.S.V.), Lima, Peru; Dana-Farber Cancer Institute (A.H.P., R.D.G.) and IBCSG Statistical Center (R.D.G.) - both in Boston; Wichita Community Clinical Oncology Program, Wichita (S.R.D.), and University of Kansas, Westwood (C.J.F.) - both in Kansas; University of Southern California Norris Cancer Center, Los Angeles (A.A.G.), the Angeles Clinic and Research Institute, Santa Monica (S.M.), and University of California at Irvine Chao Family Comprehensive Cancer Center, Orange (F.L.M) - all in California; National Cancer Institute, Division of Cancer Prevention, Bethesda, MD (L.M.); M.D. Anderson Cancer Center, Houston (G.N.H.); and Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL (K.S.A.). · Pubmed 25738668
  • Edith A. Perez, E. Aubrey Thompson, Yan W. Asmann, and Xochiquetzal J. Geiger, Mayo Clinic, Jacksonville, FL; Karla V. Ballman, S. Keith Anderson, Krishna R. Kalari, Jeanette E. Eckel-Passow, Kathleen S. Tenner, Jin Jen, Beiyun Chen, Robert B. Jenkins, and Monica M. Reinholz, Mayo Clinic, Rochester, MN; Amylou C. Dueck, and Ann E. McCullough, Mayo Clinic, Scottsdale, AZ; Jian-Bing Fan, Illumina, San Diego, CA; George W. Sledge, Stanford School of Medicine, Palo Alto, CA; Eric P. Winer, Harvard Medical School, Boston, MA; and Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA. · Edith A. Perez, E. Aubrey Thompson, Yan W. Asmann, and Xochiquetzal J. Geiger, Mayo Clinic, Jacksonville, FL; Karla V. Ballman, S. Keith Anderson, Krishna R. Kalari, Jeanette E. Eckel-Passow, Kathleen S. Tenner, Jin Jen, Beiyun Chen, Robert B. Jenkins, and Monica M. Reinholz, Mayo Clinic, Rochester, MN; Amylou C. Dueck, and Ann E. McCullough, Mayo Clinic, Scottsdale, AZ; Jian-Bing Fan, Illumina, San Diego, CA; George W. Sledge, Stanford School of Medicine, Palo Alto, CA; Eric P. Winer, Harvard Medical School, Boston, MA; and Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA. · Pubmed 25605861
2014
  • Ann H. Partridge, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center; Beverly Moy, Massachusetts General Hospital, Boston, MA; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria; Michael A. Danso, Virginia Oncology Associates, Norfolk, VA; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Nancy E. Davidson, University of Pittsburgh Cancer Institute/University of Pittsburgh Medical Center, Pittsburgh, PA; Angelo Di Leo, Sandro Pitigliani Medical Oncology Unit, Prato, Italy; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Douglas Yee, University of Minnesota/Masonic Cancer Center, Minneapolis, MN; Shelley B. Brundage, Patient Representative, Washington, DC; Maggie Wilcox, Independent Cancer Patients' Voice; and Ian E. Smith, Royal Marsden Hospital, London, United Kingdom. · Pubmed 25185096
  • Edith A. Perez, Gerardo Colon-Otero, the Mayo Clinic, Jacksonville; Eleftherios Mamounas, University of Florida Health Cancer Center-Orlando Health, Orlando, FL; Edward H. Romond, University of Kentucky, Lexington, KY; Vera J. Suman, Mayo Clinic, Rochester, MN; Jong-Hyeon Jeong, Priya Rastogi, University of Pittsburgh; Nancy E. Davidson, University of Pittsburgh Cancer Institute; Norman Wolmark, Allegheny General Hospital, Pittsburgh, PA; George Sledge, Stanford University School of Medicine, Stanford; Silvana Martino, The Angeles Clinic and Research Institute, Santa Monica, CA; Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jo Anne Zujewski, National Institutes of Health, Rockville, MD. · Edith A. Perez, Gerardo Colon-Otero, the Mayo Clinic, Jacksonville; Eleftherios Mamounas, University of Florida Health Cancer Center-Orlando Health, Orlando, FL; Edward H. Romond, University of Kentucky, Lexington, KY; Vera J. Suman, Mayo Clinic, Rochester, MN; Jong-Hyeon Jeong, Priya Rastogi, University of Pittsburgh; Nancy E. Davidson, University of Pittsburgh Cancer Institute; Norman Wolmark, Allegheny General Hospital, Pittsburgh, PA; George Sledge, Stanford University School of Medicine, Stanford; Silvana Martino, The Angeles Clinic and Research Institute, Santa Monica, CA; Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jo Anne Zujewski, National Institutes of Health, Rockville, MD. · Pubmed 25332249
  • Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA. · Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA. · Pubmed 24934783
  • Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ. · Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ. · Pubmed 24888818
2012
2010
  • Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA. · Pubmed 20368559
Probable:    University of Wisconsin   Contact    
2016
  • Department of Radiology, Massachusetts General Hospital, Boston, MA (CDL); Department of Radiology, University of Washington Medical Center, Seattle, WA (JML, DSH, GK, SCP); Seattle Cancer Care Alliance, Seattle, WA (JML, SCP); Department of Radiology, University of Wisconsin-Madison, Madison, WI (WBD); Department of Pathology, University of Washington Medical Center, Seattle, WA (MHR); Fred Hutchinson Cancer Research Center, Seattle, WA, (PP, JG); Department of Medical Oncology, University of Washington Medical Center, Seattle, WA (JG). · Department of Radiology, Massachusetts General Hospital, Boston, MA (CDL); Department of Radiology, University of Washington Medical Center, Seattle, WA (JML, DSH, GK, SCP); Seattle Cancer Care Alliance, Seattle, WA (JML, SCP); Department of Radiology, University of Wisconsin-Madison, Madison, WI (WBD); Department of Pathology, University of Washington Medical Center, Seattle, WA (MHR); Fred Hutchinson Cancer Research Center, Seattle, WA, (PP, JG); Department of Medical Oncology, University of Washington Medical Center, Seattle, WA (JG). · Pubmed 26744477
2013
  • University of Wisconsin Comprehensive Cancer Center, Madison, WI, USA. · Pubmed 23972474
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 89 total) written by Julie R. Gralow about Breast Neoplasms:

  • Resource-stratified implementation of a community-based breast cancer management programme in Peru. 2017
  • Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial. 2017
  • Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial. 2017
  • Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors. 2017
  • SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer. 2016
  • Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years. 2016
  • Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer. 2016
  • Hot flashes in breast cancer survivors: Frequency, severity and impact. 2016
  • Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226. 2016
  • Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907. 2016
Show List of Full Article Records
Google Searches

Learn more about Julie R. Gralow using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Washington
Harvard University
University of Wisconsin
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Washington
2017
  • Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Global Health, University of Washington, Seattle, WA, USA. · Department of Epidemiology, University of Washington, Seattle, WA, USA; PATH, Seattle, WA, USA. · PATH, Seattle, WA, USA. · Department of Global Health, University of Washington, Seattle, WA, USA; PATH, Seattle, WA, USA. · Department of Global Health, University of Washington, Seattle, WA, USA; Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Radiology, University of Washington, Seattle, WA, USA. · Department of Global Health, University of Washington, Seattle, WA, USA; Department of Radiation Oncology, University of Washington, Seattle, WA, USA. · Department of Global Health, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA. · Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Surgery, University of Washington, Seattle, WA, USA. Electronic address: · Pubmed 28971827
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
2016
  • Division of Hematology-Oncology, Department of Internal Medicine, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX, USA. · SWOG Statistical Center, Seattle, WA, USA. · University of Michigan, Ann Arbor, MI, USA. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Women and Infants Hospital of Rhode Island and Warren Alpert Medical School of Brown University, Providence, RI, USA. · Genentech, Inc., San Francisco, CA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Hematology Oncology Consultants, Inc., Westerville, OH, USA. · Columbus NCI Community Oncology Research Program, Columbus, OH, USA. · Loma Linda University Cancer Center, Loma Linda, CA, USA. · Gibbs Cancer Center and Research Institute/Southeast Clinical Oncology Research (SCOR) Consortium NCORP/Upstate Carolina CCOP (previous), Spartanburg, SC, USA. · Yale University, New Haven, CT, USA. · Arizona Cancer Center, Tucson, AZ, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27393622
  • University of California, Davis, California. · University of Pittsburgh, Pittsburgh, Pennsylvania. · University of Washington/Fred Hutchinson Cancer Research Center, Seattle, Washington. · AbbVie Laboratories, North Chicago, Illinois. · Pubmed 26801247
  • School of Nursing, College of Medicine, National Taiwan University, No. 1, Jen-Ai Rd., Sec. 1, Taipei, 10051, Taiwan; Department of Nursing, National Taiwan University Hospital, No. 7, Zhong-Shan S. Rd., Taipei, 10002, Taiwan. · Rice University, 6100 Main St, MS-760, Houston, TX 77005-1827, United States. · Department of Rehabilitation Medicine, University of Washington, Box 356490, 325 Ninth Avenue, Seattle, WA, 98104, United States. Electronic address: · Biobehavioral Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D5-220, Seattle, WA, 98109, United States; Department of Psychiatry and Behavioral Sciences, University of Washington, 1959 NE Pacific Street, Box 356560, Seattle, WA, 98195, United States. · Department of Psychiatry and Behavioral Sciences, University of Washington, 1959 NE Pacific Street, Box 356560, Seattle, WA, 98195, United States. · Division of Medical Oncology, University of Washington School of Medicine, 825 Eastlake Ave E., Seattle, WA, 98109-1023, United States; Breast Medical Oncology, Seattle Cancer Care Alliance, 825 Eastlake Ave East, G3-630, Seattle, WA, 98109, United States. · Pubmed 27065357
  • College of Pharmacy, University of Michigan, Ann Arbor, MI, USA. · SWOG Statistical Center, Seattle, WA, USA. · University of Michigan, School of Public Health, Ann Arbor, MI, USA. · Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA. · London Health Sciences Center/National Cancer Institute of Canada Clinical, Trials Group, London, ON, Canada. · Wichita NCORP, Wichita, KS, USA. · Kaiser Permanente NCORP, Portland, OR, USA. · Arizona Cancer Center, University of Arizona, Tucson, AZ, USA. · Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA. · Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA. · University of California Irvine Medical Center, Chao Family Comprehensive, Cancer Center, Orange, CA, USA. · Pubmed 26859101
  • Department of Radiology, Massachusetts General Hospital, Boston, MA (CDL); Department of Radiology, University of Washington Medical Center, Seattle, WA (JML, DSH, GK, SCP); Seattle Cancer Care Alliance, Seattle, WA (JML, SCP); Department of Radiology, University of Wisconsin-Madison, Madison, WI (WBD); Department of Pathology, University of Washington Medical Center, Seattle, WA (MHR); Fred Hutchinson Cancer Research Center, Seattle, WA, (PP, JG); Department of Medical Oncology, University of Washington Medical Center, Seattle, WA (JG). · Department of Radiology, Massachusetts General Hospital, Boston, MA (CDL); Department of Radiology, University of Washington Medical Center, Seattle, WA (JML, DSH, GK, SCP); Seattle Cancer Care Alliance, Seattle, WA (JML, SCP); Department of Radiology, University of Wisconsin-Madison, Madison, WI (WBD); Department of Pathology, University of Washington Medical Center, Seattle, WA (MHR); Fred Hutchinson Cancer Research Center, Seattle, WA, (PP, JG); Department of Medical Oncology, University of Washington Medical Center, Seattle, WA (JG). · Pubmed 26744477
  • Department of Oncology, Mayo Clinic, Rochester, MN, USA. · University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA. · Department of Medicine and Center for the Study of Aging and Human Development, Duke University, Durham, NC, USA. · Novant Health Oncology Specialists, Winston Salem, NC, USA. · Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY, USA. · Cancer Center Clinical Research Offices, Mayo Clinic, Rochester, MN, USA. · Department of Oncology, Johns Hopkins University, Baltimore, MD, USA. · Division of Medical Oncology, University of Washington, Seattle, WA, USA. · City of Hope, Duarte, CA, USA. · Pubmed 25994447
2015
  • Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Northwest Health Communications, Edmonds, WA, USA. · University of Wisconsin Comprehensive Cancer Center, Madison, WI, USA. · University of California, Los Angeles, CA, USA. · Acibadem Maslak Hospital Breast Health, Istanbul, Turkey. · Programme of Action for Cancer Therapy, International Atomic Energy Agency, Lisbon, Portugal. · Champalimaud Cancer Center, Lisbon, Portugal. · Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Uganda Cancer Institute, Kampala, Uganda. · Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · University Malaya Medical Centre, Kuala Lumpur, Malaysia. · Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. Electronic address: · Pubmed 25752564
  • Department of Medical Oncology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China. · Division of Nephrology, Harborview Medical Center, University of Washington, Seattle, WA, 98195, USA. · Division of Oncology, Department of Medicine, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, 98109, USA. · Department of Medicine, University of Washington, Seattle, WA, 98195, USA. · Department of Pathology, University of Washington, Seattle, WA, 98195, USA. · Division of Oncology, Department of Medicine, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, 98109, USA. · Pubmed 26197890
  • Scott D. Ramsey, Julie R. Gralow, Dana K. Mirick, William Barlow, Ruth Etzioni, and David Mummy, Fred Hutchinson Cancer Research Center; Scott D. Ramsey, Julie R. Gralow, Rahber Thariani, and David L. Veenstra, University of Washington, Seattle, WA; and N. Lynn Henry, University of Michigan, Ann Arbor, MI. · Scott D. Ramsey, Julie R. Gralow, Dana K. Mirick, William Barlow, Ruth Etzioni, and David Mummy, Fred Hutchinson Cancer Research Center; Scott D. Ramsey, Julie R. Gralow, Rahber Thariani, and David L. Veenstra, University of Washington, Seattle, WA; and N. Lynn Henry, University of Michigan, Ann Arbor, MI. · Pubmed 25332254
2014
  • Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA. · Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA. · Department of General Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA. · Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA. · Indiana Institute for Personalized Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Mayo Clinic, Scottsdale, AZ 85054, USA. · Mayo Clinic, Jacksonville, FL 32224, USA. · BCCA - Vancouver Cancer Center, Vancouver, BC, V5Z 4E6, USA. · Department of Internal Medicine , Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612, USA. · Research Advocacy Network, Plano, TX 75093, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA. · University of Washington, Seattle, WA 98195, USA. · Department of Oncology, Montefiore Hospital and Medical Center, Bronx, NY 10467, USA. · Cancer Institute and University of Pittsburgh Cancer Center, Pittsburgh, PA 15232, USA. · Department of Medicine, Stanford University, Stanford, CA 94305, USA. · Pubmed 25117820
  • University of Washington School of Medicine/Seattle Cancer Care Alliance, 825 Eastlake Avenue East, G3-630, Seattle, WA, 98109, USA, · Pubmed 24352574
  • Department of Pathology, Yale University School of Medicine, 310 Cedar Street BML116, New Haven, CT 06520, USA. · Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. · Department of Medical Oncology, Pitie-Salpetriere Hospital, 83 Boulevard de l'Hôpital, 75013 Paris, France. · Section of Biostatistics, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. · Department of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, 825 Eastlake Avenue East, Seattle, WA 98109, USA. · Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 8, New York, NY 10065, USA. · Division of Hematology/Oncology, University of Pittsburgh Cancer Institute and UPMC Cancer Center, 5150 Centre Avenue, Pittsburgh, PA 15232, USA. · 1] Department of Medical Oncology, Papageorgiou General Hospital, Aristotle University of Thessaloniki School of Medicine, Efkarpia Peripheral Road Stavroupoli, 56429 Thessaloniki, Greece [2] Hellenic Cooperative Oncology Group (HeCOG), Laskaridou 1, 11524 Athens, Greece. · Anatomic Pathology, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA. · 1] Hellenic Cooperative Oncology Group (HeCOG), Laskaridou 1, 11524 Athens, Greece [2] Second Department of Internal Medicine Propaedeutic, Oncology Section, Attikon University Hospital, University of Athens Medical School, 1 Rimini Street, Haidari, 12462 Athens, Greece. · Department of Hematology/Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA. · Pubmed 25117817
2012
  • University of Washington School of Medicine, Seattle, Washington, USA. · Pubmed 23176010
2009
  • Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington, USA. · Pubmed 19555589
2016
  • From the Massachusetts General Hospital Cancer Center, Avon International Breast Cancer Research Program (P.E.G.), Harvard Medical School (P.E.G., E.W.), and Dana-Farber Cancer Institute (E.W.), Boston; the Department of Oncology, Mayo Clinic, Rochester, MN (J.N.I., J.S.K.); Sunnybrook Odette Cancer Centre, Toronto (K.I.P.), British Columbia Cancer Agency, Vancouver (K.G.), Canadian Cancer Trials Group, Queen's University, Kingston, ON (K.W., D.T., W.R.P.), Department of Oncology, McMaster University, Hamilton, ON (T.W.), and Dalhousie University Faculty of Medicine, Moncton Hospital, Moncton, NB (S.R.) - all in Canada; Virginia Cancer Specialists-US Oncology Network, Fairfax (N.J.R.); University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill (H.M.); University of Washington School of Medicine, Seattle (J.G.); Center of Oncology and Hematology, Wilheminen Hospital, Vienna (K.S.-W.); Colorado Cancer Research Program, Denver (K.S.); Johns Hopkins Kimmel Cancer Center, Baltimore (A.C.W.); Memorial Sloan Kettering Cancer Center, New York (C.H.); University of Arizona, Tucson (A.S.); and Highlands Oncology Group, Fayetteville, AR (J.T.B.). · Pubmed 27264120
2015
  • From the Cleveland Clinic Foundation, Cleveland (H.C.F.M.); SWOG Cancer Research Group Statistical Center, Fred Hutchinson Cancer Research Center (J.M.U., W.E.B.), and Seattle Cancer Care Alliance and University of Washington (J.G.) - all in Seattle; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (K.-A.P., P.A.F.), Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) (K.-A.P., P.A.F., J.F.F.), Calvary Mater Hospital, Newcastle, NSW (F.B., J.M.L., J.F.F.), and University of Sydney, Sydney (F.B.) - all in Australia; International Breast Cancer Study Group (IBCSG), Bern, Switzerland (K.-A.P., P.A.F.); National Institute of Oncology, Budapest, Hungary (E.H.); Auckland Regional Cancer and Blood Service, Auckland, New Zealand (D.P.); Fox Chase Cancer Center, Philadelphia (L.J.G.); Instituto de Enfermedades Neoplasicas (H.L.G.) and Oncosalud SAC (C.S.V.), Lima, Peru; Dana-Farber Cancer Institute (A.H.P., R.D.G.) and IBCSG Statistical Center (R.D.G.) - both in Boston; Wichita Community Clinical Oncology Program, Wichita (S.R.D.), and University of Kansas, Westwood (C.J.F.) - both in Kansas; University of Southern California Norris Cancer Center, Los Angeles (A.A.G.), the Angeles Clinic and Research Institute, Santa Monica (S.M.), and University of California at Irvine Chao Family Comprehensive Cancer Center, Orange (F.L.M) - all in California; National Cancer Institute, Division of Cancer Prevention, Bethesda, MD (L.M.); M.D. Anderson Cancer Center, Houston (G.N.H.); and Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL (K.S.A.). · Pubmed 25738668
  • Dawn L. Hershman, Katherine D. Crew, Danielle Awad, and Heather Greenlee, Columbia University Medical Center, New York, NY; Joseph M. Unger, Danika L. Lew, and Cathee Till, Southwest Oncology Group Statistical Center; Joseph M. Unger, Julie Gralow, Danika L. Lew, Cathee Till, and Carol M. Moinpour, Fred Hutchinson Cancer Research Center, Seattle, WA; Shaker R. Dakhil, Cancer Center of Kansas, Wichita, KS; Lori M. Minasian, National Cancer Institute, Bethesda, MD; James L. Wade III, Central Illinois Community Clinical Oncology Program/Cancer Care Specialists of Central Illinois, Decatur, IL; and Frank L. Meyskens, University of California at Irvine, Chao Family Comprehensive Cancer Center, Orange, CA. · Dawn L. Hershman, Katherine D. Crew, Danielle Awad, and Heather Greenlee, Columbia University Medical Center, New York, NY; Joseph M. Unger, Danika L. Lew, and Cathee Till, Southwest Oncology Group Statistical Center; Joseph M. Unger, Julie Gralow, Danika L. Lew, Cathee Till, and Carol M. Moinpour, Fred Hutchinson Cancer Research Center, Seattle, WA; Shaker R. Dakhil, Cancer Center of Kansas, Wichita, KS; Lori M. Minasian, National Cancer Institute, Bethesda, MD; James L. Wade III, Central Illinois Community Clinical Oncology Program/Cancer Care Specialists of Central Illinois, Decatur, IL; and Frank L. Meyskens, University of California at Irvine, Chao Family Comprehensive Cancer Center, Orange, CA. · Pubmed 25940724
  • Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Pubmed 24923811
2014
  • Ann H. Partridge, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center; Beverly Moy, Massachusetts General Hospital, Boston, MA; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria; Michael A. Danso, Virginia Oncology Associates, Norfolk, VA; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Nancy E. Davidson, University of Pittsburgh Cancer Institute/University of Pittsburgh Medical Center, Pittsburgh, PA; Angelo Di Leo, Sandro Pitigliani Medical Oncology Unit, Prato, Italy; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Douglas Yee, University of Minnesota/Masonic Cancer Center, Minneapolis, MN; Shelley B. Brundage, Patient Representative, Washington, DC; Maggie Wilcox, Independent Cancer Patients' Voice; and Ian E. Smith, Royal Marsden Hospital, London, United Kingdom. · Pubmed 25185096
  • Edith A. Perez, Gerardo Colon-Otero, the Mayo Clinic, Jacksonville; Eleftherios Mamounas, University of Florida Health Cancer Center-Orlando Health, Orlando, FL; Edward H. Romond, University of Kentucky, Lexington, KY; Vera J. Suman, Mayo Clinic, Rochester, MN; Jong-Hyeon Jeong, Priya Rastogi, University of Pittsburgh; Nancy E. Davidson, University of Pittsburgh Cancer Institute; Norman Wolmark, Allegheny General Hospital, Pittsburgh, PA; George Sledge, Stanford University School of Medicine, Stanford; Silvana Martino, The Angeles Clinic and Research Institute, Santa Monica, CA; Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jo Anne Zujewski, National Institutes of Health, Rockville, MD. · Edith A. Perez, Gerardo Colon-Otero, the Mayo Clinic, Jacksonville; Eleftherios Mamounas, University of Florida Health Cancer Center-Orlando Health, Orlando, FL; Edward H. Romond, University of Kentucky, Lexington, KY; Vera J. Suman, Mayo Clinic, Rochester, MN; Jong-Hyeon Jeong, Priya Rastogi, University of Pittsburgh; Nancy E. Davidson, University of Pittsburgh Cancer Institute; Norman Wolmark, Allegheny General Hospital, Pittsburgh, PA; George Sledge, Stanford University School of Medicine, Stanford; Silvana Martino, The Angeles Clinic and Research Institute, Santa Monica, CA; Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jo Anne Zujewski, National Institutes of Health, Rockville, MD. · Pubmed 25332249
  • Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA. · Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA. · Pubmed 24934783
  • Department of Pharmacy, University of Washington, 1959 NE Pacific St, Box 357630, Seattle, WA, 98195, USA. · Pubmed 24407530
2013
  • Department of Pharmacy, University of Washington, Seattle, WA 98195, USA. · Pubmed 24236631
  • Departments of Pharmacy, Biostatistics, Epidemiology, and Health Services, University of Washington, Seattle, WA 98101, USA. · Pubmed 23833124
  • University of Washington, Seattle, WA 98195, USA. · Pubmed 23642440
2012
  • University of Washington School of Medicine, Seattle, WA 98104, USA. · Pubmed 22443523
  • Department of Surgery, Division of Surgical Oncology, University of Washington Medical Center, 1959 NE Pacific St., Seattle, WA 98195-6410, USA. · Pubmed 22723506
2011
  • Seattle Cancer Care Alliance, 825 Eastlake Ave East, Seattle, WA 98109-1023, USA. · Pubmed 21220618
  • Department of Medicine, University of Washington, Seattle, Washington, USA. · Pubmed 21750198
  • Division of Nuclear Medicine and Medical Oncology, University of Washington, Seattle, Washington 98109, USA. · Pubmed 21364034
2010
  • University of Washington, WA, USA. · Pubmed 21778572
  • Division of Nuclear Medicine, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington 98195-7987, USA. · Pubmed 20237040
  • Division of Oncology, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington 98119, USA. · Pubmed 20568589
  • Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington 98104, USA. · Pubmed 20545872
  • Medical Oncology and Nuclear Medicine, Department of Medicine, University of Washington, Seattle, Washington 98109, USA. · Pubmed 20460489
  • Division of Medical Oncology, University of Washington, 825 Eastlake Ave, E. MS G3-630, Seattle, WA 98109, USA. · Pubmed 20308661
2009
  • Medical Oncology, Fred Hutchinson Cancer Research Center/University of Washington, Seattle Cancer Care Alliance, Seattle, Washington 98109-1023, USA. · Pubmed 19925032
  • Department of Medicine, Medical Oncology, University of Washington School of Medicine, Seattle, WA, USA. · Pubmed 19732686
Harvard University
2016
  • Department of Radiology, Massachusetts General Hospital, Boston, MA (CDL); Department of Radiology, University of Washington Medical Center, Seattle, WA (JML, DSH, GK, SCP); Seattle Cancer Care Alliance, Seattle, WA (JML, SCP); Department of Radiology, University of Wisconsin-Madison, Madison, WI (WBD); Department of Pathology, University of Washington Medical Center, Seattle, WA (MHR); Fred Hutchinson Cancer Research Center, Seattle, WA, (PP, JG); Department of Medical Oncology, University of Washington Medical Center, Seattle, WA (JG). · Department of Radiology, Massachusetts General Hospital, Boston, MA (CDL); Department of Radiology, University of Washington Medical Center, Seattle, WA (JML, DSH, GK, SCP); Seattle Cancer Care Alliance, Seattle, WA (JML, SCP); Department of Radiology, University of Wisconsin-Madison, Madison, WI (WBD); Department of Pathology, University of Washington Medical Center, Seattle, WA (MHR); Fred Hutchinson Cancer Research Center, Seattle, WA, (PP, JG); Department of Medical Oncology, University of Washington Medical Center, Seattle, WA (JG). · Pubmed 26744477
2016
  • From the Massachusetts General Hospital Cancer Center, Avon International Breast Cancer Research Program (P.E.G.), Harvard Medical School (P.E.G., E.W.), and Dana-Farber Cancer Institute (E.W.), Boston; the Department of Oncology, Mayo Clinic, Rochester, MN (J.N.I., J.S.K.); Sunnybrook Odette Cancer Centre, Toronto (K.I.P.), British Columbia Cancer Agency, Vancouver (K.G.), Canadian Cancer Trials Group, Queen's University, Kingston, ON (K.W., D.T., W.R.P.), Department of Oncology, McMaster University, Hamilton, ON (T.W.), and Dalhousie University Faculty of Medicine, Moncton Hospital, Moncton, NB (S.R.) - all in Canada; Virginia Cancer Specialists-US Oncology Network, Fairfax (N.J.R.); University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill (H.M.); University of Washington School of Medicine, Seattle (J.G.); Center of Oncology and Hematology, Wilheminen Hospital, Vienna (K.S.-W.); Colorado Cancer Research Program, Denver (K.S.); Johns Hopkins Kimmel Cancer Center, Baltimore (A.C.W.); Memorial Sloan Kettering Cancer Center, New York (C.H.); University of Arizona, Tucson (A.S.); and Highlands Oncology Group, Fayetteville, AR (J.T.B.). · Pubmed 27264120
  • Stuart M. Lichtman and Maria Theodoulou, Memorial Sloan Kettering Cancer Center, New York, NY; Constance T. Cirrincione, Duke University; Harvey Jay Cohen, Duke University Medical Center, Durham; Gustave Magrinat, Cone Health Cancer Center, Greensboro; Hyman B. Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte, CA; Aminah Jatoi, Mayo Clinic, Rochester, MN; Antonio C. Wolff, The Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD; Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA; and Daniel E. Morganstern, Dana-Farber Cancer Institute, Boston, MA. · Stuart M. Lichtman and Maria Theodoulou, Memorial Sloan Kettering Cancer Center, New York, NY; Constance T. Cirrincione, Duke University; Harvey Jay Cohen, Duke University Medical Center, Durham; Gustave Magrinat, Cone Health Cancer Center, Greensboro; Hyman B. Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte, CA; Aminah Jatoi, Mayo Clinic, Rochester, MN; Antonio C. Wolff, The Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD; Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA; and Daniel E. Morganstern, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 26755510
2015
  • From the Cleveland Clinic Foundation, Cleveland (H.C.F.M.); SWOG Cancer Research Group Statistical Center, Fred Hutchinson Cancer Research Center (J.M.U., W.E.B.), and Seattle Cancer Care Alliance and University of Washington (J.G.) - all in Seattle; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (K.-A.P., P.A.F.), Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) (K.-A.P., P.A.F., J.F.F.), Calvary Mater Hospital, Newcastle, NSW (F.B., J.M.L., J.F.F.), and University of Sydney, Sydney (F.B.) - all in Australia; International Breast Cancer Study Group (IBCSG), Bern, Switzerland (K.-A.P., P.A.F.); National Institute of Oncology, Budapest, Hungary (E.H.); Auckland Regional Cancer and Blood Service, Auckland, New Zealand (D.P.); Fox Chase Cancer Center, Philadelphia (L.J.G.); Instituto de Enfermedades Neoplasicas (H.L.G.) and Oncosalud SAC (C.S.V.), Lima, Peru; Dana-Farber Cancer Institute (A.H.P., R.D.G.) and IBCSG Statistical Center (R.D.G.) - both in Boston; Wichita Community Clinical Oncology Program, Wichita (S.R.D.), and University of Kansas, Westwood (C.J.F.) - both in Kansas; University of Southern California Norris Cancer Center, Los Angeles (A.A.G.), the Angeles Clinic and Research Institute, Santa Monica (S.M.), and University of California at Irvine Chao Family Comprehensive Cancer Center, Orange (F.L.M) - all in California; National Cancer Institute, Division of Cancer Prevention, Bethesda, MD (L.M.); M.D. Anderson Cancer Center, Houston (G.N.H.); and Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL (K.S.A.). · Pubmed 25738668
  • Edith A. Perez, E. Aubrey Thompson, Yan W. Asmann, and Xochiquetzal J. Geiger, Mayo Clinic, Jacksonville, FL; Karla V. Ballman, S. Keith Anderson, Krishna R. Kalari, Jeanette E. Eckel-Passow, Kathleen S. Tenner, Jin Jen, Beiyun Chen, Robert B. Jenkins, and Monica M. Reinholz, Mayo Clinic, Rochester, MN; Amylou C. Dueck, and Ann E. McCullough, Mayo Clinic, Scottsdale, AZ; Jian-Bing Fan, Illumina, San Diego, CA; George W. Sledge, Stanford School of Medicine, Palo Alto, CA; Eric P. Winer, Harvard Medical School, Boston, MA; and Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA. · Edith A. Perez, E. Aubrey Thompson, Yan W. Asmann, and Xochiquetzal J. Geiger, Mayo Clinic, Jacksonville, FL; Karla V. Ballman, S. Keith Anderson, Krishna R. Kalari, Jeanette E. Eckel-Passow, Kathleen S. Tenner, Jin Jen, Beiyun Chen, Robert B. Jenkins, and Monica M. Reinholz, Mayo Clinic, Rochester, MN; Amylou C. Dueck, and Ann E. McCullough, Mayo Clinic, Scottsdale, AZ; Jian-Bing Fan, Illumina, San Diego, CA; George W. Sledge, Stanford School of Medicine, Palo Alto, CA; Eric P. Winer, Harvard Medical School, Boston, MA; and Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA. · Pubmed 25605861
2014
  • Ann H. Partridge, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center; Beverly Moy, Massachusetts General Hospital, Boston, MA; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria; Michael A. Danso, Virginia Oncology Associates, Norfolk, VA; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Nancy E. Davidson, University of Pittsburgh Cancer Institute/University of Pittsburgh Medical Center, Pittsburgh, PA; Angelo Di Leo, Sandro Pitigliani Medical Oncology Unit, Prato, Italy; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Douglas Yee, University of Minnesota/Masonic Cancer Center, Minneapolis, MN; Shelley B. Brundage, Patient Representative, Washington, DC; Maggie Wilcox, Independent Cancer Patients' Voice; and Ian E. Smith, Royal Marsden Hospital, London, United Kingdom. · Pubmed 25185096
  • Edith A. Perez, Gerardo Colon-Otero, the Mayo Clinic, Jacksonville; Eleftherios Mamounas, University of Florida Health Cancer Center-Orlando Health, Orlando, FL; Edward H. Romond, University of Kentucky, Lexington, KY; Vera J. Suman, Mayo Clinic, Rochester, MN; Jong-Hyeon Jeong, Priya Rastogi, University of Pittsburgh; Nancy E. Davidson, University of Pittsburgh Cancer Institute; Norman Wolmark, Allegheny General Hospital, Pittsburgh, PA; George Sledge, Stanford University School of Medicine, Stanford; Silvana Martino, The Angeles Clinic and Research Institute, Santa Monica, CA; Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jo Anne Zujewski, National Institutes of Health, Rockville, MD. · Edith A. Perez, Gerardo Colon-Otero, the Mayo Clinic, Jacksonville; Eleftherios Mamounas, University of Florida Health Cancer Center-Orlando Health, Orlando, FL; Edward H. Romond, University of Kentucky, Lexington, KY; Vera J. Suman, Mayo Clinic, Rochester, MN; Jong-Hyeon Jeong, Priya Rastogi, University of Pittsburgh; Nancy E. Davidson, University of Pittsburgh Cancer Institute; Norman Wolmark, Allegheny General Hospital, Pittsburgh, PA; George Sledge, Stanford University School of Medicine, Stanford; Silvana Martino, The Angeles Clinic and Research Institute, Santa Monica, CA; Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jo Anne Zujewski, National Institutes of Health, Rockville, MD. · Pubmed 25332249
  • Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA. · Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA. · Pubmed 24934783
  • Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ. · Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ. · Pubmed 24888818
2012
2010
  • Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA. · Pubmed 20368559
University of Wisconsin
2016
  • Department of Radiology, Massachusetts General Hospital, Boston, MA (CDL); Department of Radiology, University of Washington Medical Center, Seattle, WA (JML, DSH, GK, SCP); Seattle Cancer Care Alliance, Seattle, WA (JML, SCP); Department of Radiology, University of Wisconsin-Madison, Madison, WI (WBD); Department of Pathology, University of Washington Medical Center, Seattle, WA (MHR); Fred Hutchinson Cancer Research Center, Seattle, WA, (PP, JG); Department of Medical Oncology, University of Washington Medical Center, Seattle, WA (JG). · Department of Radiology, Massachusetts General Hospital, Boston, MA (CDL); Department of Radiology, University of Washington Medical Center, Seattle, WA (JML, DSH, GK, SCP); Seattle Cancer Care Alliance, Seattle, WA (JML, SCP); Department of Radiology, University of Wisconsin-Madison, Madison, WI (WBD); Department of Pathology, University of Washington Medical Center, Seattle, WA (MHR); Fred Hutchinson Cancer Research Center, Seattle, WA, (PP, JG); Department of Medical Oncology, University of Washington Medical Center, Seattle, WA (JG). · Pubmed 26744477
2013
  • University of Wisconsin Comprehensive Cancer Center, Madison, WI, USA. · Pubmed 23972474
University of Michigan
2015
  • Scott D. Ramsey, Julie R. Gralow, Dana K. Mirick, William Barlow, Ruth Etzioni, and David Mummy, Fred Hutchinson Cancer Research Center; Scott D. Ramsey, Julie R. Gralow, Rahber Thariani, and David L. Veenstra, University of Washington, Seattle, WA; and N. Lynn Henry, University of Michigan, Ann Arbor, MI. · Scott D. Ramsey, Julie R. Gralow, Dana K. Mirick, William Barlow, Ruth Etzioni, and David Mummy, Fred Hutchinson Cancer Research Center; Scott D. Ramsey, Julie R. Gralow, Rahber Thariani, and David L. Veenstra, University of Washington, Seattle, WA; and N. Lynn Henry, University of Michigan, Ann Arbor, MI. · Pubmed 25332254
2014
  • Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ. · Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ. · Pubmed 24888818
2012
  • University of Michigan, Division of Hematology/Oncology, 24 Frank Lloyd Wright Drive, Suite A3400, PO Box 483, Ann Arbor, Michigan 48106, USA. · Pubmed 22267853
Miscellaneous institutions in Seattle
2015
  • Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. · Genomic Health, Inc, 301 Penobscot Drive, Redwood City, CA, 94063, USA. · Department of Health Sciences Research, University of California, 500 Parnassus Avenue, San Francisco, CA, 94143, USA. · Genomic Health, Inc, 301 Penobscot Drive, Redwood City, CA, 94063, USA. · Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. · Alliance Statistics and Data Center, Mayo Clinic, 13400 E. Shea Boulevard, Scottsdale, AZ, USA. · Genomic Health, Inc, 301 Penobscot Drive, Redwood City, CA, 94063, USA. · Genomic Health, Inc, 301 Penobscot Drive, Redwood City, CA, 94063, USA. · Genomic Health, Inc, 301 Penobscot Drive, Redwood City, CA, 94063, USA. · Genomic Health, Inc, 301 Penobscot Drive, Redwood City, CA, 94063, USA. · Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH, 03766, USA. · University of Pittsburgh Cancer Institute, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA. · Seattle Cancer Care Alliance, 825 Eastlake Avenue East, Seattle, WA, 98109, USA. · Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. · Alliance Statistics and Data Center, 200 1st Street SW, Mayo Clinic, Rochester, MN, 55905, USA. · Pubmed 26429296
2014
  • Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA. · Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · SWOG Statistical Center, Seattle, WA, USA. · Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, OH, USA. · Columbia University Medical Center, Columbia University, New York, NY, USA. · Department of medicine, Baystate Medical Center, Springfield, MA, USA. · Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Mayo Clinic, Rochester, MN, USA. · Allan Blair Cancer Centre, Regina, SK, Canada. · Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Seattle Cancer Care Alliance, Seattle, WA, USA. · College of Medicine, Arizona Cancer Center, Tucson, AZ, USA. · Loyola University Chicago Cardinal Bernardin Cancer Center, Maywood, IL, USA. · Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. · Pubmed 23999597
2013
  • Seattle Cancer Care Alliance, 825 Eastlake Ave. E, G3-630, Seattle, WA 98019-1023, USA. · Pubmed 23313061
2009
  • Breast Cancer Education & Outreach, Seattle Cancer Care Alliance, 825 Eastlake Ave. E, G3-630, Seattle, WA 98109, USA. · Pubmed 19967289
84 Other Locations Show
Yearly article counts 0489121291215710
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.